BRUKER CORPORATION Proceeds from (Payments to) Noncontrolling Interests
BRUKER CORPORATION (BRKR) reported Proceeds from (Payments to) Noncontrolling Interests of -$14.70 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromPaymentsToMinorityShareholders · last filed 2025-03-03
- BRUKER CORPORATION proceeds from (payments to) noncontrolling interests for the quarter ending 2024-12-31 was -$13.70M.
- BRUKER CORPORATION proceeds from (payments to) noncontrolling interests for the quarter ending 2024-09-30 was $0.00.
- BRUKER CORPORATION proceeds from (payments to) noncontrolling interests for the quarter ending 2024-06-30 was -$100.00K.
- BRUKER CORPORATION proceeds from (payments to) noncontrolling interests for the quarter ending 2024-03-31 was -$900.00K, a 116.98% decline year-over-year.
- BRUKER CORPORATION proceeds from (payments to) noncontrolling interests for fiscal 2024 was -$14.70M, a 590.00% decline from fiscal 2023.
- BRUKER CORPORATION proceeds from (payments to) noncontrolling interests for fiscal 2023 was $3.00M.
- BRUKER CORPORATION proceeds from (payments to) noncontrolling interests for fiscal 2022 was -$11.80M.
- BRUKER CORPORATION proceeds from (payments to) noncontrolling interests for fiscal 2021 was $0.00.
| Period end | Proceeds from (Payments to) Noncontrolling Interests 3 month | Proceeds from (Payments to) Noncontrolling Interests 6 month | Proceeds from (Payments to) Noncontrolling Interests 9 month | Proceeds from (Payments to) Noncontrolling Interests 12 month |
|---|---|---|---|---|
| 2024-12-31 | -$13.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$13.70M derived: sum of 2 quarters · filed 2025-03-03 | -$13.80M derived: sum of 3 quarters · filed 2025-03-03 | -$14.70M 10-K · filed 2025-03-03 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$100.00K derived: sum of 2 quarters · filed 2024-11-07 | -$1.00M 10-Q · filed 2024-11-07 | -$1.50M derived: sum of 4 quarters · filed 2025-03-03 |
| 2024-06-30 | -$100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | -$1.00M 10-Q · filed 2024-08-09 | -$1.50M derived: sum of 3 quarters · filed 2025-03-03 | -$3.00M derived: sum of 4 quarters · filed 2025-03-03 |
| 2024-03-31 | -$900.00K 10-Q · filed 2024-05-10 | -$1.40M derived: sum of 2 quarters · filed 2025-03-03 | -$2.90M derived: sum of 3 quarters · filed 2025-03-03 | -$3.20M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-12-31 | -$500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$2.00M derived: sum of 2 quarters · filed 2025-03-03 | -$2.30M derived: sum of 3 quarters · filed 2025-03-03 | $3.00M 10-K · filed 2025-03-03 |
| 2023-09-30 | -$1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$1.80M derived: sum of 2 quarters · filed 2024-11-07 | $3.50M 10-Q · filed 2024-11-07 | $2.30M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $5.00M 10-Q · filed 2024-08-09 | $3.80M derived: sum of 3 quarters · filed 2025-03-03 | $600.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $5.30M 10-Q · filed 2024-05-10 | $4.10M derived: sum of 2 quarters · filed 2025-03-03 | $900.00K derived: sum of 3 quarters · filed 2025-03-03 | |
| 2022-12-31 | -$1.20M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$4.40M derived: sum of 2 quarters · filed 2025-03-03 | -$11.80M 10-K · filed 2025-03-03 | |
| 2022-09-30 | -$3.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$10.60M 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | -$7.40M 10-Q · filed 2023-08-09 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |